We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
13.00 | 0.79% | 1,649.00 | 1,648.50 | 1,649.50 | 1,656.00 | 1,635.00 | 1,642.00 | 1,667,570 | 12:34:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.78 | 67.93B |
TIDMGSK
RNS Number : 8431P
GlaxoSmithKline PLC
22 August 2014
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4 R(1)(a) I give details of changes in the interests of Mr J Ford, a Person Discharging Managerial Responsibilities, in the Ordinary Shares of GlaxoSmithKline (GSK). GSK was advised on 22 August 2014, that following the vesting on 1 August 2014 of 25% of an award made on 1 August 2008, under the GlaxoSmithKline Deferred Investment Award Plan, Mr J Ford will receive a cash payment of 1419.00p per share in respect of 3717.464194 notional Ordinary Shares on 29 August 2014.
V A Whyte
Company Secretary
22 August 2014
.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBLLFLZVFBBBQ
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions